Innovative Program Seeks Patients Who Can Benefit From MASH Treatment
An innovative program is bringing together officials, community and industry leaders, and health care providers in four major U.S. cities to address the growing but still underrecognized challenge of metabolic dysfunction-associated steatohepatitis and metabolic dysfunction-associated steatotic liver disease.